Background Septic shock remains a major cause of mortality
T halassemia is a critical health problem in children since it leads to growth and developmental disorders. 1 In 1994, The World Health Organization (WHO) reported that 5.2% of the world's population had the thalassemia trait and that increased to 7% in 2001. 2 Each year, there are about 300,000 infants born with thalassemia major worldwide. In Indonesia, the incidence of β-thalassemia, a-thalassemia, and hemoglobin (Hb) E carriers are 10%, 1.2 to 11%, and 1.5 to 36%, respectively. 3 Due to medical advances in thalassemia management, most patients achieve normal growth in their first decade. However, significant growth disorders and delayed puberty may occur in adolescence, 4 because of insulin-like growth factor-1 (IGF-1) deficiency. A multicenter study conducted in Italy and Qatar reported that 67% of thalassemic adults had IGF-1 deficiency (IGFD). 5 In addition, an Iranian study showed lower mean IGF-1 levels in children with thalassemia [61.33 (SD 67.64) ng/mL] compared to healthy children [126.93 (SD 156.7) ng/mL]. 6 Several factors contributing to the reduction of IGF-1 synthesis include transfusion-induced iron overload, chronic anemia, undernutrition, impaired thyroid function, and high levels of alanine transaminase (ALT). 7 Hence, we aimed to assess such factors for associations with low IGF-1 levels in children with thalassemia major.
Methods
We conducted a retrospective study in outpatient clinics of two hospitals in Indonesia, namely, Dr. Sarjito Hospital, Yogyakarta and Dr. Moewardi Hospital, Surakarta, Central Java, from July to December 2015. We recruited children with thalassemia major aged 2 to 18 years, who were diagnosed based on Hb electrophoresis results. Those who had complete medical records, including ferritin and pre-transfusion hemoglobin levels over the past year, thyroidstimulating hormone (TSH), free thyroxine (FT4), and ALT levels, were included in the study. We obtained written informed consent from subjects' parents or guardians.
We performed history-taking and medical record reviews to collect the following data: age at diagnosis of thalassemia, Hb electrophoresis results, as well as mean ferritin, pre-transfusion hemoglobin, TSH, FT4, and ALT levels over the past year. The nutritional status were defined by mid upper arm circumference (MUAC), which was measured at the midpoint between the tip of the shoulder and the tip of the elbow (olecranon process and the acromium), and classified according to the classification of Frisanchoas as followed: below adequate (≤ 5 th percentile), adequate (between 5 th and 95 th percentile), and above adequate (≥95 th percentile). The IGF-1 levels were measured at Prodia Laboratory Surakarta, by an automated chemiluminescence immunoassay (Immulite®2000), using a solid-phase, enzyme-labeled chemiluminescent immunometric assay. A reference range study performed with DPC's IMMULITE IGF-I kit ( Table 1) . 8 The blood was collected at least a week before blood transfusions to avoid elevation of IGF-1 levels due to the transfusion.
Data on the characteristics of subjects were summarized as proportion, mean, or median, where appropriate. We performed a simple linear regression analysis to evaluate for correlations between IGF-1 level and nutritional status, mean ferritin level, mean pre-transfusion hemoglobin level, thyroid function, and ALT level. Pearson's/Spearman's correlation coefficient was used to analyze the strength of linear relationships between variables. The decision in hypothesis testing was based on the significance level of P<0.05. 9 The data were analysed using SPSS 15 software. This study was approved by the Health Research Ethics Committee of the Universitas Gadjah Mada Faculty of Medicine, Public Health and Nursing, Yogyakarta, Indonesia.
Results
A total of 48 patients were recruited into the study, 12 children from Dr. Sarjito Hospital and 36 children from Dr. Moewardi Hospital. Subjects' characteristics are presented in Table 2 . The number of males and females was similar and subjects had a mean of age was 11 (SD 3.6) years. Their mean duration of thalassemia diagnosis in this study was 7.65 (SD 3.60, range 1.2-14.5) years. Subjects mean ferritin level in the past year was 3,568 (SD 2131.3) 3) μg/L, with a range of 25 to 491 ng/mL. The majority of the children (75%) had IGF-1 level of less than -2SD, and the rest ranged between -1SD and -2SD. None of the children had IGF-1 levels above the reference value. (Figure 1) . The equation The correlation between ferritin and IGF-1 level was negative, but weak and not statistically significant (r=-1.048; 95%CI to 0.22 to 0.003; P=0.301) (Figure 3) .
Multivariate analyses revealed similar results, with pre-transfusion Hb level (β=0.090; 95%CI -0.002 to 0.182; P=0.056) and nutritional status 
Discussion
Most thalassemia patients (75%) in our study had low IGF-1 levels [mean 109.3 (SD 90.3) μg/L]. Similarly, a previous study reported that 67% of patients with thalassemia had IGF-1 levels < -2SD. 5 Chronic anemia in thalassemia can cause hypoxia in hepatocytes. This hypoxic state can inhibit protein synthesis in the liver, which leads to increased IGF-binding proteins specific (IGFBPs), especially IGFBP-1. The increased IGFBP-1 may inhibit IGF-1 function by binding to to it and preventing IGF-1 from binding to the IGF-1 receptor (IGF-1R). 9, 11 Repeated blood transfusions in thalassemia major patients may cause elevated levels of free iron in blood serum, which then converts hydrogen peroxide into hydroxide ion (OH-), leading to increased reactive oxygen species (ROS) and oxidative stress. 12 Increased ROS decreases mRNA expression of IGF-1, leading to muscle atrophy, sarcomopenia, wasting, and myopathy. On the other hand, decreased ROS will increase IGF-1 levels, have a positive effect on skeletal muscle protein balance, as well as prevent oxidative damage and other chronic diseases. 13 Our subjects' mean ferritin level was 3,568 (SD 2,131.31) ng/mL, which was higher than reported in an Iranian study [2, 962 (SD 1, 606 ) ng/mL]. 14 Another study in Malaysia documented that optimal growth in thalassemia major patients can be achieved if their mean ferritin level is less than 2,271 (SD 1804) ng/mL. 15 Several factors can affect ferritin levels in thalassemia patients, including blood transfusion frequency and regularity of iron chelation therapy. 16 We did not analyze factors affecting high ferritin levels in this study because there was no medical record data on the blood transfusion frequency and adherence to iron chelation therapy.
According to Standards of Care Guidelines for Thalassemia 2009, Hb levels in children with thalassemia major are ideally maintained at 9-10 g/dL in order to achieve optimal growth. 17 In our study, mean pre-transfusion hemoglobin level was 8.0 (SD 0.9). We noted that Hb level was positively and significantly correlated with IGF-1 level in thalassemia major patients in the univariate analysis (r=2.380; P=0.022), but not in the multivariate analysis.
Micronutrients play a role in growth, protein and DNA synthesis, neurosensory function, immunity, thyroid function, and bone metabolism. Some micronutrients are known to affect IGF-1 level, including magnesium, selenium and zinc. There are two mechanisms involved in the relationship between these nutrients and IGF-1: oxidative stress and inflammation. Micronutrient deficiency increases oxidative stress, free radicals, and oxygen peroxidase production, but decreases antioxidant enzyme expression, which then leads to down-regulated IGF-1 secretion. 18, 19 In our study, nutritional status was assessed by measuring MUAC, due to organomegaly in hepatocytes and/or hemodynamics in thalassemic children. The proportion of subjects in nutritional status categories (64.6% adequate and 35.4% severly depleted) was different from a study conducted in Iran (39.3% adequate and 60.7% severly depleted). 6 Other studies reported the prevalences of severly depleted in thalassemic children to be 64% and 49%, respectively. 6, 20 As such, we seemed to have a higher proportion of well-nourished children in our study population. Nonetheless, poor nournishment was significantly correlated to decreased IGF-1 levels. Decreased IGF-1 level in undernourished thalassemic children is caused by elevated interleukin-1β (IL-1β), tumor necrosis factor-a (TNF-a), and interleukin-6 (IL-6) secretion in micronutrient deficient conditions. The IL-6 is a major proinflammatory cytokine with a negative effect on muscle function and IGF-1 synthesis. 21 We noted the prevalence of hypothyroidism in thalassemic children was 8.3%, but this prevalence can vary by country. Previous studies conducted in Indonesia, Iran, and Turkey reported hypothyroidism prevalences of 20%, 6%, and 12.8%, respectively. [22] [23] [24] A previous study found that ALT levels were significantly correlated with IGF-I levels (r=0.26; P=0.05) in thalassemia major patients, 7 contrary to the findings by De Sanctis et al. who found no significant relationship between ALT and IGF-1 levels (r=0.01; P>0.05). 24 A limitation of our study that should be considered was that we did not examine IGFBPs levels which can affect IGF-1 levels in the circulation. Moreover, we did not assess factors affecting ferritin levels and nutritional status, such as dietary intake and nutritional interventions.
In conclusion, univariate analysis shows that pre-transfusion hemoglobin levels and nutritional status significantly correlate with IGF-1 levels in children with thalassemia major. Those whose mean pre-transfusion Hb level is less than 8 g/dL and with undernutrition typically have lower IGF-1 levels.
